In vivo conversion of dopamine neurons in mouse models of Parkinson's disease - a future approach for regenerative therapy?

Research output: Contribution to journalReview articlepeer-review

Abstract

Recent advances in cell reprogramming have made it possible to form new therapeutic cells within the body itself via a process called direct conversion or lineage reprogramming. A series of studies have shown that it is possible to reprogram resident glia into new neurons within the brain parenchyma. These studies opened up for the targeted attempts to achieve functional brain repair using in vivo conversion. Because of the relatively focal degeneration, Parkinson's Disease (PD) is an attractive target for both transplantation-based and in vivo conversion-based reparative approaches. Fetal cell transplants have provided proof-of-concept and stem cell-based therapies for PD are now on the verge of entering clinical trials. In the future, in vivo conversion may be an alternative to transplantation-based therapies.

Original languageEnglish
Pages (from-to)76-82
JournalCurrent Opinion in Genetics & Development
Volume70
Issue number0
Early online date2021 Jun 24
DOIs
Publication statusPublished - 2021 Oct 1

Subject classification (UKÄ)

  • Neurosciences

Fingerprint

Dive into the research topics of 'In vivo conversion of dopamine neurons in mouse models of Parkinson's disease - a future approach for regenerative therapy?'. Together they form a unique fingerprint.

Cite this